ADDPHARMA
AddPharma develops new drugs, established by the gathering of key personnel who have successfully developed new drugs for many companies for decades. Adpharma is accelerating the development of new and improved drugs based on its long-established technology for complexes, release control agents, and absorption improvers.
ADDPHARMA
Founded:
2017-01-01
Address:
Giheung, Kyonggi-do, South Korea
Country:
South Korea
Website Url:
http://www.addpharma.co.kr
Total Employee:
51+
Status:
Active
Technology used in webpage:
Euro SSL By Default Nginx CrUX Top 50m CrUX Dataset Sectigo SSL Sectigo Domain SSL Korea Telecom
Similar Organizations
Avenzoar Pharmaceuticals
Avenzoar Pharmaceuticals is a pharmaceutical company developing cancer drugs.
GenEros Biopharma
GenEros Biopharma is a biopharmaceutical company that develops autoimmune and anti-inflammation therapeutics.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Mankind Pharma
Mankind Pharma is a pharmaceutical company that develops, commercializes, and delivers medicines for urgent medical needs.
SmartNuclide
SmartNuclide is a biopharmaceutical company that develops biological drug products.
Takeda
Takeda is a biopharmaceutical company that researches and develops pharmaceutical drugs.
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries is a pharmaceutical company specializing in the development, production and marketing of generic.
VC Cell Therapy
VC Cell Therapy is a pharmaceutical company that provides regenerative medicines.
Official Site Inspections
http://www.addpharma.co.kr Semrush global rank: 14.06 M Semrush visits lastest month: 63
- Host name: mail210.webmaker21.kr
- IP address: 115.68.17.210
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "Addpharma"
Addpharma, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Nov 1, 2024 www.addpharma.co.kr. Private Company | 2017 | Gyeonggi-do, South Korea | 50-100 | www.addpharma.co.kr. Last update 01 Nov 2024. Overview. Pipeline. Deal. โฆSee details»
Addpharma - Crunchbase Company Profile & Funding
AddPharma develops new drugs, established by the gathering of key personnel who have successfully developed new drugs for many companies for โฆSee details»
www.addpharma.co.kr
J:ลÔHMs;ÿßtökù û7ลพb8ÁÈ6¤ฦ§ L) #l ลก86ãBòÛb·โข¿Ó»ºÖÐ ï/1«Cโ\L#ล v±85EoÌt ôÈลþýZ¥; ¹ 22 aหm"tTtêÁÿ©îลพโขª ªê9Üå¹ uxñý×0xÀ $ .J@ù8ฦÂÜkX6¹6Ûwß&ล โฌล ¸ÏíLÏS *©Ç7โ²ฦ UM$ þX โ โฆSee details»
Addpharma Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Addpharma Inc. of Yongin, Gyeonggi. Get the latest business insights from Dun & Bradstreet.See details»
Organization | Addpharma Inc.
Addpharma Inc. Report issue. For profit Phase 1 Phase 2 Phase 3. Founded: Seoul Korea, Republic of (2017 ... Organization Overview. First Clinical Trial. 2018 NCT03586037. First โฆSee details»
Addpharma | VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and โฆSee details»
Addpharma, Inc.: Drug pipelines, Patents, Clinical trials - Synapse
|www.addpharma.co.kr. Last update 02 Aug 2023See details»
Found - addpharma.co.kr
์ ๋ํ๋งใ์ ์์น ์ ๋ณด๋ฅผ ์ ๊ณตํ๋ ์นํ์ด์ง์ ๋๋ค.See details»
Found - addpharma.co.kr
Found. The document has moved here.See details»
AD-211 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 AD-211, Initially developed by Addpharma, Inc., Now, its global highest R&D status is Phase 1, Therapeutic Areas: Nervous System Diseases, Active Indication: Pain ...See details»
Addpharma Company Profile 2024: Valuation, Funding & Investors โฆ
Addpharma General Information Description. Operator of an online pharmacy intended to help people on their path to improved health. The company's pharmacy offers a range of healthcare โฆSee details»
Addpharma - Overview, News & Similar companies | ZoomInfo.com
Addpharma Inc is a company that operates in the Electrical/Electronic Manufacturing industry. It employs 21-50 people and has $5M-$10M of revenue. ... South Korea. Website. โฆSee details»
AD-104 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 Addpharma, Inc. KCT0009332 / Completed Phase 1 An open label, randomized, single dose, 2-sequence, 2-period, cross-over phase 1 study to evaluate the safety and โฆSee details»
AD-227A and AD-227B and AD-227C in Essential Hypertension
May 29, 2024 A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227B July 30, 2024 updated by: Addpharma Inc. A Multicenter, Randomized, Double โฆSee details»
AD 202 - AdisInsight - Springer
Feb 1, 2023 If your organization has a subscription, there are several access options, even while working remotely: Working within your organizationโs network Login with username/password โฆSee details»
AD-201 - Drug Targets, Indications, Patents - Synapse - Patsnap
An open-label, randomized, 2-sequence, 4-period, sinlge-dose, repeated-crossover study to evaluate the pharmacokinetics and the safety of AD-201 compared to coadministration of AD โฆSee details»
Home 1 - AddPharma | Pharmacy in Ghana
Visited @addpharma today and their services was awesome. I strongly recommend Addpharma to everyone. Very affordable pricing and excellent customer service. Alexander Ashitey August โฆSee details»
Addpharma - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and โฆSee details»
AD 110 - AdisInsight
If your organization has a subscription, there are several access options, even while working remotely: Working within your organizationโs network Login with username/password or try to โฆSee details»
AD 203 - AdisInsight - Springer
If your organization has a subscription, there are several access options, even while working remotely: Working within your organizationโs network Login with username/password or try to โฆSee details»